The neutrophil-lymphocyte ratio to predict poor prognosis of critical acute myocardial infarction patients: a retrospective cohort study

Introduction Inflammation is closely related to adverse outcomes of acute myocardial infarction (AMI). This study aimed to evaluate whether neutrophil-lymphocyte ratio (NLR) can predict poor prognosis of critical AMI patients. Materials and methods We designed a retrospective cohort study and extracted AMI patients from the “Medical Information Mart for Intensive Care-III” database. The primary outcome was 1-year all-cause mortality. The secondary outcomes were 90-day and in-hospital all-cause mortalities, and acute kidney injury (AKI) incidence. The optimal cut-offs of NLR were picked by X-tile software according to the 1-year mortality and patient groups were created: low-NLR (< 4.8), high-NLR (4.8 - 21.1), and very high-NLR (> 21.1). Cox and modified Poisson regression models were used to evaluate the effect of NLR on outcomes in critically AMI patients. Results Finally, 782 critical AMI patients were enrolled in this study, and the 1-year mortality was 32% (249/782). The high- and very high-NLR groups had a higher incidence of outcomes than the low-NLR group (P < 0.05). The multivariate regression analyses found that the high- and very high-NLR groups had a higher risk of 1-year mortality (Hazard ratio (HR) = 1.59, 95% CI: 1.12 to 2.24, P = 0.009 and HR = 1.73, 95% CI: 1.09 to 2.73, P = 0.020), 90-day mortality (HR = 1.69, 95% CI: 1.13 to 2.54, P = 0.011 and HR = 1.90, 95% CI: 1.13 to 3.20, P = 0.016), in-hospital mortality (Relative risk (RR) = 1.77, 95% CI: 1.14 to 2.74, P = 0.010 and RR = 2.10, 95% CI: 1.23 to 3.58, P = 0.007), and AKI incidence (RR = 1.44, 95% CI: 1.06 to 1.95, P = 0.018 and RR = 1.34, 95% CI: 0.87 to 2.07, P = 0.180) compared with low-NLR group. NLR retained stable predictive ability in sensitivity analyses. Conclusion Baseline NLR is an independent risk factor for 1-year mortality, 90-day mortality, in-hospital mortality, and AKI incidence in AMI patients.

[1]  Min Chul Kim,et al.  Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio Combined With Anemia in Patients With ST-Segment Elevation Myocardial Infarction: A Nationwide Prospective Cohort Study , 2021, Journal of lipid and atherosclerosis.

[2]  J. Douglas,et al.  Geographic Variation and Temporal Trends in Management and Outcomes of Cardiac Arrest Complicating Acute Myocardial Infarction in the United States. , 2021, Resuscitation.

[3]  V. Liakopoulos,et al.  Association between Biomarkers of Oxidative Stress and Inflammation with Cardiac Necrosis and Heart Failure in Non-ST Segment Elevation Myocardial Infarction Patients and Various Degrees of Kidney Function , 2021, Oxidative medicine and cellular longevity.

[4]  Yu-yu Yao,et al.  The Neutrophil-to-Lymphocyte Ratio Is an Important Indicator Predicting In-Hospital Death in AMI Patients , 2021, Frontiers in Cardiovascular Medicine.

[5]  Yuzhou Xue,et al.  Prognostic value of neutrophil‐lymphocyte ratio in cardiogenic shock complicating acute myocardial infarction: A cohort study , 2021, International journal of clinical practice.

[6]  Meifang Wu,et al.  Predictive value of neutrophil to lymphocyte ratio and red cell distribution width on death for ST segment elevation myocardial infarction , 2021, Scientific Reports.

[7]  Yibin Wang,et al.  The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19 , 2021, Cell Metabolism.

[8]  Cheng-gang Zhu,et al.  Differential leukocyte counts and cardiovascular mortality in very old patients with acute myocardial infarction: a Chinese cohort study , 2020, BMC Cardiovascular Disorders.

[9]  H. Yan,et al.  [Associations between postprocedural D-dimer, hs-CRP, LDL-C levels and prognosis of acute myocardial infarction patients treated by percutaneous coronary intervention]. , 2020, Zhonghua xin xue guan bing za zhi.

[10]  Yenn-Jiang Lin,et al.  Systemic immune‐inflammation index (SII) predicted clinical outcome in patients with coronary artery disease , 2020, European journal of clinical investigation.

[11]  G. Dan,et al.  The neutrophil to lymphocyte ratio in heart failure: a comprehensive review , 2019, Romanian journal of internal medicine = Revue roumaine de medecine interne.

[12]  Zhiwei Huang,et al.  Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: A meta-analysis. , 2019, The American journal of emergency medicine.

[13]  J. Oh,et al.  Prognostic implications of post-percutaneous coronary intervention neutrophil-to-lymphocyte ratio on infarct size and clinical outcomes in patients with acute myocardial infarction , 2019, Scientific Reports.

[14]  M. Budoff,et al.  Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study. , 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  B. Caballero.  Humans against Obesity: Who Will Win? , 2019, Advances in nutrition.

[16]  M. Gianni,et al.  Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: A systematic review and meta-analysis of the literature. , 2018, International journal of cardiology.

[17]  C. Cannon,et al.  Acute myocardial infarction , 2017, The Lancet.

[18]  P. Forget,et al.  What is the normal value of the neutrophil-to-lymphocyte ratio? , 2017, BMC Research Notes.

[19]  J. Cigarroa,et al.  2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2016, The Journal of thoracic and cardiovascular surgery.

[20]  T. Celik,et al.  The neutrophil-lymphocyte ratio and atherosclerosis , 2016, Expert review of cardiovascular therapy.

[21]  Ruochi Zhao,et al.  [Value of neutrophils/lymphocytes ratio on predicting the prognosis of patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention:a meta-analysis]. , 2015, Zhonghua xin xue guan bing za zhi.

[22]  T. Turker,et al.  Neutrophil–Lymphocyte Ratio and Carotid–Intima Media Thickness in Patients With Behçet Disease Without Cardiovascular Involvement , 2015, Angiology.

[23]  Ben Tran,et al.  Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. , 2014, Journal of the National Cancer Institute.

[24]  Daniela M. Witten,et al.  An Introduction to Statistical Learning: with Applications in R , 2013 .

[25]  Erling Falk,et al.  Update on acute coronary syndromes: the pathologists' view. , 2013, European heart journal.

[26]  J. Kellum,et al.  Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1) , 2013, Critical Care.

[27]  N. Frangogiannis,et al.  Regulation of the inflammatory response in cardiac repair. , 2012, Circulation research.

[28]  Patrick Royston,et al.  The cost of dichotomising continuous variables , 2006, BMJ : British Medical Journal.

[29]  E. Tuzcu,et al.  Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease , 2005 .

[30]  D. Rimm,et al.  X-Tile , 2004, Clinical Cancer Research.

[31]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[32]  W. Ao,et al.  The correlation between PLR-NLR and prognosis in acute myocardial infarction. , 2021, American journal of translational research.

[33]  Kristopher J Preacher,et al.  On the practice of dichotomization of quantitative variables. , 2002, Psychological methods.

[34]  R. Záhorec.  Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill. , 2001, Bratislavske lekarske listy.